Literature DB >> 20095309

Primary antibody deficiencies: recognition, clinical diagnosis and referral of patients.

Philip Wood1.   

Abstract

The primary antibody deficiency syndromes are a rare group of immunodeficiencies where diagnostic delay remains common due to limited awareness of the existence and heterogeneity of their presenting features. Referral for specialist assessment leads to earlier diagnosis and appropriate therapy to prevent or limit structural organ and tissue damage. Greater education of healthcare professionals is required to ensure prompt recognition and referral to specialists with expertise in the care of primary immunodeficiencies, especially since study of these rare conditions is a minor part of undergraduate and general postgraduate training. Greater awareness would lead to reduced morbidity, improved quality of life and survival outcomes in this patient group.

Entities:  

Mesh:

Year:  2009        PMID: 20095309      PMCID: PMC4952305          DOI: 10.7861/clinmedicine.9-6-595

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  16 in total

1.  Immune globulin intravenous (human), 5% liquid gammaplex: for replacement therapy of primary humoral immunodeficiency.

Authors: 
Journal:  P T       Date:  2011-06

2.  Privigen immune globulin intravenous (human), 10% liquid.

Authors: 
Journal:  P T       Date:  2011-08

3.  The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017.

Authors:  B Shillitoe; C Bangs; D Guzman; A R Gennery; H J Longhurst; M Slatter; D M Edgar; M Thomas; A Worth; A Huissoon; P D Arkwright; S Jolles; H Bourne; H Alachkar; S Savic; D S Kumararatne; S Patel; H Baxendale; S Noorani; P F K Yong; C Waruiru; V Pavaladurai; P Kelleher; R Herriot; J Bernatonienne; M Bhole; C Steele; G Hayman; A Richter; M Gompels; C Chopra; T Garcez; M Buckland
Journal:  Clin Exp Immunol       Date:  2018-06       Impact factor: 4.330

4.  Studies on trypsin inhibitor in barley. I. Purification and some properties.

Authors:  T Ogiso; T Noda; Y Sako; Y Kato; M Aoyama
Journal:  J Biochem       Date:  1975-07       Impact factor: 3.387

Review 5.  Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update.

Authors:  E de Vries
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 6.  New frontiers of primary antibody deficiencies.

Authors:  Mirjam van der Burg; Menno C van Zelm; Gertjan J A Driessen; Jacques J M van Dongen
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

Review 7.  Development of a vaccine against Staphylococcus aureus.

Authors:  Brad Spellberg; Robert Daum
Journal:  Semin Immunopathol       Date:  2011-11-14       Impact factor: 9.623

Review 8.  Lung Disease in Primary Antibody Deficiencies.

Authors:  Edith Schussler; Mary B Beasley; Paul J Maglione
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

9.  Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency.

Authors:  Tamar Weinberger; Ramsay Fuleihan; Charlotte Cunningham-Rundles; Paul J Maglione
Journal:  J Clin Immunol       Date:  2019-05-14       Impact factor: 8.317

10.  A humoral immune defect distinguishes the response to Staphylococcus aureus infections in mice with obesity and type 2 diabetes from that in mice with type 1 diabetes.

Authors:  Christopher W Farnsworth; Cindy T Shehatou; Robert Maynard; Kohei Nishitani; Stephen L Kates; Michael J Zuscik; Edward M Schwarz; John L Daiss; Robert A Mooney
Journal:  Infect Immun       Date:  2015-03-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.